Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Natural product-based therapy for Cancer: Curcumin, the major component of turmeric, decreases the negative regulator of p53, MDM2, via up regulation of its target miRNA, 27/August/2014, 09.57 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: Curcumin, by increasing the expression of its target miRNA, it may decrease the negative regulator p53, MDM2. Thereby, it may increase the expression of tumor suppressor p53. Thus, pharmacological formulations encompassing “Curcumin or its analogues” may be used to treat cancer.